This paper presents our indications for angioplasty of intracranial stenoses in secondary prevention of stroke.
This technique was first implemented at our institution in 1993. Inclusion criteria are very strict: severe stenoses located on large arteries, symptomatic despite antithrombotic therapy.
Thirty patients have been successfully treated to date. Twenty-seven patients are free of symptoms with a mean follow-up of four years. Neurological complications occurred in two patients. One patient developed an early symptomatic restenosis.
Intracranial angioplasty is feasible and efficient for stroke prevention but inclusion criteria should remain strict.
SaccoRLKargmanDE: Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study. Stroke26: 14–20, 1995.
2.
BogousslavskyJBarnettHJM: Atherosclerotic disease of the middle cerebral artery. Stroke17: 1112–1120, 1986.
3.
ChimowitzMIKokkinosJ: The warfarin-aspirin symptomatic intracranial disease study. Neurology45: 1488–1493, 1995.
4.
MarksMPMarcellusM: Outcome of angioplasty for atherosclerotic intracranial stenosis. Stroke30: 1065–1069, 1999.
5.
MoriTMoriK: Percutaneous transluminal cerebral angioplasty: Serial angiographic follow-up after successful dilatation. Neuroradiology39: 111–116, 1997.
6.
TeradaTHigashidaRT: Transluminal angioplasty for arteriosclerotic disease of the distal vertebral and basilar arteries. J Neurol Neurosurg Psychiatry60: 377–381, 1996.
